T80.61XA Other serum reaction due to administration of blood and blood products, initial encounter

Name of the Condition

• Other serum reaction due to administration of blood and blood products, initial encounter.

Summary

This condition describes an adverse reaction to serum or blood products that is not classified elsewhere, occurring during the initial encounter. It involves immune or non-immune responses to components in blood or plasma derivatives, potentially affecting multiple organ systems.

Causes

Reactions may result from immune-mediated responses (e.g., allergic or anaphylactic reactions) or non-immune mechanisms (e.g., contamination, hemolysis, or cytokine release). The specific trigger depends on the blood product type and patient sensitivities.

Risk Factors

• Prior exposure to blood products
• History of allergic reactions
• Underlying immune disorders
• Use of multiple blood product types
• Pre-existing conditions (e.g., IgA deficiency)

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, urticaria, or angioedema)
• Respiratory distress (wheezing, dyspnea)
• Hypotension or tachycardia
• Nausea, vomiting, or headache
• Flank pain or hemoglobinuria (if hemolysis occurs)

Diagnosis

Diagnosis requires correlation of clinical symptoms with the timing of blood product administration. Laboratory tests (e.g., hemolysis markers, immunoglobulin levels) and imaging may help identify the reaction type. Documentation of the product lot, type, and administration details is essential.

Treatment Options

Management focuses on discontinuing the offending product, supportive care (e.g., fluids, antihistamines, or vasopressors), and addressing specific symptoms. Severe reactions may require epinephrine or corticosteroids.

Prognosis and Follow-Up

Outcomes vary based on reaction severity and promptness of treatment. Most mild reactions resolve with supportive care, while severe cases may require intensive monitoring. Follow-up includes assessing for delayed complications and avoiding future exposures.

Complications

• Anaphylactic shock
• Acute kidney injury (from hemolysis)
• Transfusion-related acute lung injury (TRALI)
• Sepsis (if contaminated products were used)

Lifestyle & Prevention

• Use leukoreduced or washed blood products for high-risk patients
• Screen donors for infectious agents
• Administer pre-medication (e.g., antihistamines) for known sensitivities
• Monitor patients closely during and after transfusion

When to Seek Professional Help

Seek immediate care for signs of severe reaction (e.g., respiratory distress, hypotension, or altered mental status) or if symptoms worsen after initial treatment.

Tips for Medical Coders

Document the specific blood product administered, reaction onset, and clinical findings. Ensure "initial encounter" is confirmed, as this code is for the first episode of the reaction. Include details on product type (e.g., plasma, platelets) and any interventions performed.